We are live on ! Find out more
JAM

JW Asset Management Portfolio holdings

AUM $244M
1-Year Est. Return 71.51%
This Fund
S&P 500
This Quarter Est. Return
+11.91%
1 Year Est. Return
+71.51%
3 Year Est. Return
+125.61%
5 Year Est. Return
+131.61%
10 Year Est. Return
+2,490.27%
AUM
$268M
AUM Growth
-$8.07M
Cap. Flow
-$32.2M
Cap. Flow %
-12.01%
Top 10 Hldgs %
76.83%
Holding
59
New
3
Increased
6
Reduced
16
Closed
16

Top Buys

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$12.1M
2
AMZN icon
Amazon
AMZN
+$7.57M
3
META icon
Meta Platforms (Facebook)
META
+$6.1M
4
WING icon
Wingstop
WING
+$1.27M
5
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$708K

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$16.8M
2
NFLX icon
Netflix
NFLX
+$6.28M
3
BWLD
Buffalo Wild Wings, Inc.
BWLD
+$6.03M
4
KYTH
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
+$4.34M
5
BX icon
Blackstone
BX
+$4.05M

Sector Composition

Rank Sector Weight
1 Healthcare 70.14%
2 Consumer Discretionary 11.44%
3 Communication Services 11.39%
4 Financials 3.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EGRX
1
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$76M 28.38%
857,679
+8,970
+1% +$708K
CXRX
2
DELISTED
Concordia International Corp. Common Stock
CXRX
$21.8M 8.15%
534,800
-22,700
-4% -$799K
NFLX icon
3
Netflix
NFLX
$305B
$18.6M 6.93%
1,624,840
-550,000
-25% -$6.28M
HZNP
4
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$14.6M 5.44%
673,075
-100,824
-13% -$1.96M
SBUX icon
5
Starbucks
SBUX
$119B
$13.8M 5.17%
230,690
+198,000
+606% +$12.1M
AGN
6
DELISTED
Allergan plc
AGN
$13.8M 5.15%
44,189
+2,000
+5% +$595K
AMZN icon
7
Amazon
AMZN
$2.49T
$13.7M 5.13%
406,780
+240,000
+144% +$7.57M
META icon
8
Meta Platforms (Facebook)
META
$1.51T
$12M 4.46%
114,186
+59,410
+108% +$6.1M
REGN icon
9
Regeneron Pharmaceuticals
REGN
$72.8B
$11.4M 4.27%
21,080
-31,000
-60% -$16.8M
INSY
10
DELISTED
Insys Therapeutics, Inc.
INSY
$10M 3.75%
350,978
-37,368
-10% -$1.04M
BX icon
11
Blackstone
BX
$105B
$8.64M 3.22%
295,421
-127,049
-30% -$4.05M
ALXN
12
DELISTED
Alexion Pharmaceuticals
ALXN
$6.38M 2.38%
33,424
– –
AVDL
13
DELISTED
Avadel Pharmaceuticals
AVDL
$6.16M 2.3%
504,439
-65,380
-11% -$1.02M
ASRT
14
DELISTED
Assertio
ASRT
$5.71M 2.13%
5,254
– –
QLTI
15
DELISTED
QLT Inc
QLTI
$4.24M 1.58%
1,592,993
– –
LGND icon
16
Ligand Pharmaceuticals
LGND
$5.87B
$3.92M 1.46%
57,987
– –
JNP
17
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$3.38M 1.26%
328,132
-153,327
-32% -$1.78M
JAZZ icon
18
Jazz Pharmaceuticals
JAZZ
$16.3B
$3.17M 1.18%
22,559
-10,000
-31% -$1.39M
BSTC
19
DELISTED
BioSpecifics Technologies Corp.
BSTC
$3.12M 1.16%
72,649
-937
-1% -$46.9K
PRGO icon
20
Perrigo
PRGO
$1.46B
$2.78M 1.04%
19,243
-16,943
-47% -$2.61M
WING icon
21
Wingstop
WING
$3.9B
$2.65M 0.99%
116,057
+54,000
+87% +$1.27M
IPXL
22
DELISTED
Impax Laboratories, Inc.
IPXL
$2.28M 0.85%
53,373
-10,000
-16% -$399K
CBM
23
DELISTED
Cambrex Corporation
CBM
$1.91M 0.71%
40,573
– –
SGNT
24
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$1.62M 0.6%
101,630
-5,000
-5% -$78.7K
TARO
25
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$1.05M 0.39%
6,783
-13,529
-67% -$1.98M
1
2 3

Similar funds

SC
Schulhoff & Co Cincinnati, Ohio $243M AUM 17.47% 1-Year Est. Return
HCM
Hutner Capital Management Manchester, Vermont $243M AUM 10.01% 1-Year Est. Return
SC
Solstein Capital Menlo Park, California $244M AUM 29.05% 1-Year Est. Return
HBS
Howard Bailey Securities Fort Wayne, Indiana $243M AUM 13.36% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return
IFO
Independent Family Office Albany, New York $243M AUM 21.81% 1-Year Est. Return
VG
Visualize Group New York $243M AUM 6.21% 1-Year Est. Return
CP
Creekside Partners Petaluma, California $243M AUM 20.23% 1-Year Est. Return

JW Asset Management's Q4 2015 Portfolio in Review

As of Q4 2015, JW Asset Management held 59 positions worth $268M, down 2.9% from $276M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

JW Asset Management withdrew a net $32.2M in Q4 2015, closing 16 positions and reducing 16 holdings. Its most notable exit was Buffalo Wild Wings, Inc., an estimated $6.03M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, down from 74% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, JW Asset Management opened a new position in WW International worth $431K.

  • JW Asset Management's largest Q4 2015 buy was WW International: 18,890 shares worth $431K.
  • JW Asset Management added most to Starbucks in Q4 2015, an estimated $12.1M increase.
  • JW Asset Management's biggest Q4 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $16.8M.
  • JW Asset Management fully exited Buffalo Wild Wings, Inc. in Q4 2015, selling an estimated $6.03M.
  • JW Asset Management's ten largest holdings make up 77% of its $268M portfolio in Q4 2015.
  • JW Asset Management opened 3 new positions and closed 16 in Q4 2015.
  • JW Asset Management's portfolio value fell 2.9% quarter-over-quarter to $268M.

Based on JW Asset Management's 13F filing for Q4 2015, filed 9 Feb 2016.